Literature DB >> 4159616

Treatment of chronic portal-systemic encephalopathy with lactulose.

J Bircher, J Müller, P Guggenheim, U P Haemmerli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4159616     DOI： 10.1016/s0140-6736(66)91573-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  56 in total

Review 1.  Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.

Authors:  T Gerber; H Schomerus
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  The normal colonic bacterial flora.

Authors:  M J Hill; B S Drasar
Journal:  Gut       Date:  1975-04       Impact factor: 23.059

3.  Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy.

Authors:  S P Bird; D Hewitt; B Ratcliffe; M I Gurr
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 4.  Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.

Authors:  Bodil Als-Nielsen; Lise L Gluud; Christian Gluud
Journal:  BMJ       Date:  2004-03-30

5.  Motor vehicle accidents: how should cirrhotic patients be managed?

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 6.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

Review 7.  The treatment of hepatic encephalopathy.

Authors:  Marsha Y Morgan; A Blei; K Grüngreiff; R Jalan; G Kircheis; G Marchesini; O Riggio; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

8.  Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis.

Authors:  G P van Berge Henegouwen; S D van der Werf; A T Ruben
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

9.  Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.

Authors:  C Cammà; F Fiorello; F Tinè; G Marchesini; A Fabbri; L Pagliaro
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

10.  Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.

Authors:  P L Lanthier; M Y Morgan
Journal:  Gut       Date:  1985-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.